Results are presented as mean S.E.M
He X, Wang X, Yang L, Yang Z, Yu W, Wang Y et al (2022) Intelligent lesion bloodbrain barrier targeting nano-missiles for Alzheimers disease treatment by anti-neuroinflammation and neuroprotection
However, tirzepatide demonstrates a dose-dependent effect on glycaemia: at 5 mg once weekly, 27% of people with type 2 diabetes achieved an HbA 1c below 5.7%, compared with 46% at 15 mg once weekly
Immune cell function is finely regulated by nutrient availability, and targeting metabolic activity is a recurrent strategy for malignant cells to proliferate
Therefore, following the approval of Exenatide, development of GLP-1 drugs mainly focused on two directions: developing long-acting GLP-1RAs and oral GLP-1RAs (Figure 3)